0001209191-24-002090.txt : 20240123
0001209191-24-002090.hdr.sgml : 20240123
20240123171338
ACCESSION NUMBER: 0001209191-24-002090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240121
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME ALLISON
CENTRAL INDEX KEY: 0001573886
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 24553445
MAIL ADDRESS:
STREET 1: C/O SOPHIRIS BIO INC., 1258 PROSPECT ST
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-21
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001573886
HULME ALLISON
C/O VENTYX BIOSCIENCES, INC.
12790 EL CAMINO REAL, SUITE 200
SAN DIEGO
CA
92130
1
0
0
0
0
Stock Option (right to buy)
1.97
2024-01-21
4
A
0
20000
0.00
A
2034-01-21
Common Stock
20000
20000
D
The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will
accelerate and fully vest, subject to the reporting person continuing to be an Outside Director (as the term is defined in the Company's Amended and Restated Outside Director Compensation Policy) through the date of the Change in Control.
/s/ Christopher Krueger, as Attorney-in-Fact
2024-01-23